Patents by Inventor Klaus-Peter Schwabe

Klaus-Peter Schwabe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6328999
    Abstract: The invention relates to extracts from ginkgo biloba leaves with a reduced 4′-O-methyl pyridoxine and biflavones content, to a method for the production thereof and to medicaments containing said extracts.
    Type: Grant
    Filed: May 25, 2000
    Date of Patent: December 11, 2001
    Assignee: Dr. Willmar Schwabe GmbH & Co.
    Inventor: Klaus-Peter Schwabe
  • Patent number: 5512286
    Abstract: The present application relates to an extract from the leaves of Ginkgo biloba containing most of the flavone glycosides, ginkgolides and bilobalide originally present in the leaves, characterized in that it is essentially free of components of the leaves with serum-precipitating and/or haemagglutinating properties, method of its preparation and pharmaceutical compositions containing the extract.
    Type: Grant
    Filed: February 23, 1994
    Date of Patent: April 30, 1996
    Assignee: Dr. Willmar Schwabe GmbH & Co.
    Inventor: Klaus-Peter Schwabe
  • Patent number: 5399348
    Abstract: The invention relates to an improved extract from Ginkgo biloba leaves, a method of preparation of the same and pharmaceuticals containing the extract.
    Type: Grant
    Filed: June 24, 1992
    Date of Patent: March 21, 1995
    Assignee: Dr. Willmar Schwabe GmbH & Co.
    Inventor: Klaus-Peter Schwabe
  • Patent number: 5322688
    Abstract: The invention relates to a method of preparation of an improved extract from Ginkgo biloba leaves and to pharmaceuticals containing the extract.
    Type: Grant
    Filed: June 15, 1992
    Date of Patent: June 21, 1994
    Assignee: Dr. Willmar Schwabe GmbH & Co.
    Inventor: Klaus-Peter Schwabe
  • Patent number: 5296224
    Abstract: Dry extract from kava-kava drug having a total content of kava lactones of at least 50% by weight and a flavokawin content of at the most 0.3% by weight. The extract is distinguished by good water solubility and high bioavailability after oral administration. To increase the kava lactone content in the extract and decrease the flavokawin content, a process is proposed in which the raw extract is brought into solution and the content of flavokawins diminished by cold precipitation or by solvent distribution, whereafter the solution is concentrated to dryness. Drugs are made using the dry extract.
    Type: Grant
    Filed: May 7, 1992
    Date of Patent: March 22, 1994
    Assignee: Dr. Wilmar Schwabe GmbH & Co.
    Inventor: Klaus-Peter Schwabe